Abstract
Diabetic people are more prone to hypertension than those without this metabolic disorder (1–6). More than 3 million people in the United States have both type II diabetes and hypertension (1–3). Cardiovascular disease (CVD) is the largest cause of morbidity and mortality in diabetic persons with coexistent hypertension. Accordingly, a major focus of hypertension therapy for these persons should be the reduction of CVD morbidity and mortality, while reducing the complications of diabetic nephropathy. The causation of this comorbidity in Westernized societies may be attributed to populations getting older, more obese, and more sedentary (1–6). Up to 80% of the premature mortality in persons with this diabetes is due to CVD (1–6). Hypertension plays a key role in promoting CVD in diabetic persons (1–6). These observations have contributed to the recommendations of more aggressive lowering of blood pressure (BP) (i.e., to <130/85 mmHg) in people with both diabetes and hypertension (2–7). However, it appears that most of such persons are inadequately controlled at this desired BP (5,8). New strategies are being reviewed to improve our ability to reach BPs in this high-risk population.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sowers JR, Epstein M (1995) Diabetes mellitus and associated hypertension, vascular disease and nephropathy: an update. Hypertension 26: 869–879.
The National High Blood Pressure Education Program Working Group (Chair, James R. Sowers, MD) (1994) National high blood pressure education program working group report on hypertension in diabetes. Hypertension 23: 145–158 (special article).
American Diabetes Association (1996) Clinical practice recommendations: hypertension in diabetes. Diabetes Care 19 (Suppl. 1): S107 — S113.
Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (1997) The sixth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-VI). Arch Intern Med 157: 2413–2446.
Bakris GL, Weir MR, Sowers JR (1996) Therapeutic challenges in the obese, diabetic patient with hypertension. Am J Med 101: 33S - 46S.
Afonso LC, Edelson GL, Sowers JR (1997) Metabolic abnormalities in hypertension. Curr Opin Nephrol Hypertens 6: 219–223.
Estacio RO, Jeffers BW, Hiatt WR, Bigerstaff SL, Gifford N, Schrier RW (1998) The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 338: 645–652.
Burt VL, Cutler JA, Higgins M (1995) Trends in the prevalence, awareness, treatment and control of hypertension in the adult U.S. population: data from the Health Examination Surveys, 1960 to 1991. Hypertension 26: 60–69.
Mykkünen L, Kuusisti J, Pyorala K, Laakso M, Haffner SM (1994) Increased risk of non-insulin dependent diabetes mellitus in elderly hypertensive subjects. J Hypertens 12: 1425–1432.
Schrier RW (1998) Antihypertensive treatment in type II diabetes. Hosp Pract 33(5): 13, 14.
Sowers JR, Farrow SL (1996) Treatment of elderly hypertensive patients with diabetes, renal disease and coronary heart disease. Am J Cardiol 6 (5): 57–60.
Sowers JR, Sowers PS, Peuler JD (1993) Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis. J Lab Clin Med 123: 647–652.
Landin K, Tengborn L, Smith U (1990) Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med 227: 273–278.
Fakuda K, Ozaki Y, Satoh K, et al. (1997) Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: Correlation with spontaneous aggregation. Diabetes 46: 488–493.
McMillen DE (1997) Development of vascular complications in diabetes. Vasc Med 2: 132–142.
Sowers JR (1997) Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 29: 691–699.
Dinneen SF, Gerstein HC (1997) The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 157: 1413–1418.
Estacio RO, Schrier RW (1998) Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial. Am J Cardiol 12 (9B): 9R - 14R.
UKPDS Group (1998) UK Prospective Diabetes Study 38: tight blood pressure control and risk of macrovascular and macrovascular complications in type 2 diabetes. BMJ 317: 703–713.
UK Prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837–853.
Curb JD, Pressel MS, Cutler JA, et al. (1996) Effect of a diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated hypertension. JAMA 276: 1886–1892.
Sowers JR (1999) Hypertension in type II diabetes: update on therapy. J Clin Hypertens 1: 41–47.
Hansson L, Zanchetti A, Carruthers SB, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S (1998) Effects of intensive blood pressure-lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Study Group. Lancet 351: 1755–1762.
Staussen JA, Fagard R, Thys L, for the Systolic Hypertension-Europe (SystEur) trial investigators (1997) Morbidity and mortality in the placebo-controlled European trial on isolated systolic hypertension in the elderly. Lancet 350: 757–764.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sowers, K.M.R., Sowers, J.R. (2001). Diabetes and Hypertension. In: Weber, M.A. (eds) Hypertension Medicine. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-008-7_34
Download citation
DOI: https://doi.org/10.1007/978-1-59259-008-7_34
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5446-9
Online ISBN: 978-1-59259-008-7
eBook Packages: Springer Book Archive